Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/11/25
End: 03/24/26
Due: 03/24/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease | NCT06489340 | ZyVersa Therapeutics, Inc. | user2@example.com | None | 2025-06-11 | 2026-03-24 | 2027-03-24 | - | - | 2025-07-14 |